Adage Capital Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Adage Capital Partners’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,163,140	Closed	-$45.8M	–	979
2023 Q2	$45.8M	Buy	1,163,140 +1,084,140	+1,372%	+$38.3M	0.1%	205
2023 Q1	$1.92M	Buy	+79,000	New	+$1.73M	﹤0.01%	768
2022 Q4	–	Sell	-850,000	Closed	-$15.2M	–	1071
2022 Q3	$15.2M	Buy	850,000 +630,000	+286%	+$8.27M	0.04%	507
2022 Q2	$2.12M	Sell	220,000 -280,000	-56%	-$3.51M	﹤0.01%	872
2022 Q1	$8.41M	Buy	+500,000	New	+$7.39M	0.02%	740

Adage Capital Partners's ISEE Position: Q3 2023 in Review

Adage Capital Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 1,163,140 shares — an estimated $45.8M sold.

Adage Capital Partners first reported a position in ISEE in Q1 2022 and held it in 5 quarters. The position peaked at $45.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Adage Capital Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Adage Capital Partners sold 1,163,140 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $45.8M.
Adage Capital Partners first reported a position in IVERIC bio, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Adage Capital Partners's IVERIC bio, Inc. Common Stock position peaked at $45.8M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Adage Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.